Status:
COMPLETED
Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Healthy
Polyuria-polydipsia Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.
Eligibility Criteria
Inclusion
- Age over 18 years
- No medication except hormonal contraception
Exclusion
- Evidence of any acute illness
- Subjects refusing or unable to give written informed consent
- Pregnancy
- Any evidence of disordered drinking habits and diuresis
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01879137
Start Date
June 1 2013
End Date
May 1 2017
Last Update
July 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4031